Frg Family Wealth Advisors LLC Gilead Sciences, Inc. Transaction History

Frg Family Wealth Advisors LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $7,158 - $8,729	100 New	100 $7,000
Q3 2019 Mar 02, 2022	SELL	$62.51 - $69.0 $204,282 - $225,492	-3,268 Closed	0 $0
Q2 2019 Mar 02, 2022	SELL	$61.87 - $69.38 $137,970 - $154,717	-2,230 Reduced 40.56%	3,268 $221,000
Q1 2019 Mar 02, 2022	SELL	$62.53 - $70.05 $56,089 - $62,834	-897 Reduced 14.03%	5,498 $357,000
Q4 2018 Mar 02, 2022	SELL	$60.54 - $79.0 $299,975 - $391,445	-4,955 Reduced 43.66%	6,395 $400,000
Q3 2018 Mar 02, 2022	SELL	$71.28 - $78.92 $155,034 - $171,651	-2,175 Reduced 16.08%	11,350 $876,000
Q2 2018 Mar 02, 2022	SELL	$64.88 - $75.68 $327,319 - $381,805	-5,045 Reduced 27.17%	13,525 $958,000
Q1 2018 Mar 02, 2022	SELL	$72.84 - $88.8 $10,926 - $13,320	-150 Reduced 0.8%	18,570 $1.4 Million
Q4 2017 Mar 02, 2022	SELL	$71.15 - $83.52 $229,814 - $269,769	-3,230 Reduced 14.72%	18,720 $1.34 Million
Q3 2017 Mar 02, 2022	SELL	$72.11 - $85.47 $91,940 - $108,974	-1,275 Reduced 5.49%	21,950 $1.78 Million
Q2 2017 Mar 02, 2022	SELL	N/A	-1,125 Reduced 4.62%	23,225 $1.64 Million
Q1 2017 Mar 02, 2022	BUY	N/A	4,260 Added 21.2%	24,350 $1.64 Million
Q4 2016 Mar 02, 2022	BUY	N/A	1,255 Added 6.66%	20,090 $1.44 Million
Q3 2016 Mar 02, 2022	BUY	N/A	2,805 Added 17.5%	18,835 $1.49 Million
Q2 2016 Mar 02, 2022	BUY	N/A	3,460 Added 27.53%	16,030 $1.34 Million
Q1 2016 Mar 02, 2022	BUY	N/A	1,850 Added 17.26%	12,570 $1.16 Million
Q4 2015 Mar 02, 2022	BUY	N/A	10,720	10,720 $1.09 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Frg Family Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Frg Family Wealth Advisors LLC with notifications on news.